ArticleSurgical endoscopy2025
The first multicenter study of robot-assisted breast-conserving surgery: insights from the KoREa-BSG group.
Article in Surgical endoscopy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Global evolution, intellectual structure, and emerging themes in robot-assisted breast oncologic surgery and cancer-related reconstruction: a bibliometric analysis.Journal of robotic surgery · 2026Article
- Robotic versus endoscopic breast-conserving surgery: a comparative analysis of clinical outcomes and aesthetic outcomes in breast cancer.Journal of robotic surgery · 2026Article
- Cutting-edge trends in da Vinci single-port robotic approaches to breast surgery: a narrative review.Annals of surgical treatment and research · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRobot-assisted breast-conserving surgery has a potentially better cosmetic benefit than conventional breast-conserving surgery without any scarring on the breast. However, data on the feasibility and safety are limited. This study presents the results of early robot-assisted breast-conserving surgery.
methodsA multi-center retrospective review was conducted to identify women who underwent robot-assisted breast- conserving surgery between August 2019 and October 2023. Information on the clinicopathological characteristics, perioperative complications, operation time, recurrence, and reoperation was collected.
resultsA total of 150 patients underwent the surgery performed by ten breast surgeons at seven institutions. Invasive breast cancer was observed in 121 cases and ductal carcinoma in situ was detected in 29 cases. Of all the patients, 75.3% and 65.3% had an estrogen and progesterone receptor positive status, respectively. A total of 35.3% of the patients had a HER2-positive status. In terms of the surgical technique, the Da Vinci SP system was more frequently used (60%). Gas insufflation was applied in 97.33% of the cases, and sentinel lymph node biopsy was the most common axillary surgery (89.3%). The median postoperative days was 5.4 days. The incision location was the mid-axillary line, and the median incision length was 37.1 mm. The median total operation time was 133.8 min. Eleven cases (7.3%) had positive frozen margins, and only one case (0.7%) required reoperation because of permanent positive margin. Six patients (4%) developed surgical complications. Postoperative bleeding was found in one case and skin burns were found in five cases (3.3%). There were no cases of conversion to open surgery or of mortality. Two patient (1.3%) had recurrence.
conclusionsThis is the first multicenter report on robot-assisted breast-conserving surgery, suggesting the technique is feasible and safe. Further comparative and prospective studies are warranted to evaluate patient satisfaction, cost-effectiveness, and long-term surgical and oncological outcomes.
Indexed as
Identifiers
40789780What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.